The St. Anna Children's Cancer Research Institute (CCRI) in Vienna primarily focuses on advanced research and training in pediatric oncology, rather than traditional academic courses. However, it offers specialized educational programs, workshops, and training modules for researchers, clinicians, and students interested in childhood cancer research. These programs emphasize translational research, combining basic science with clinical applications to improve treatments for young cancer patients.
- Pediatric Oncology Research Training: This intensive program covers molecular biology of childhood cancers, including leukemias and solid tumors. Participants learn advanced techniques in genomics, proteomics, and immunotherapy, with hands-on lab sessions simulating real-world research scenarios. The curriculum spans 6-12 months and includes seminars on ethical considerations in pediatric research.
- Translational Medicine Workshops: Focused on bridging lab discoveries to bedside applications, these short courses (2-4 weeks) teach drug development, clinical trial design, and biomarker identification specific to pediatric cancers. Experts from CCRI's labs guide participants through case studies of successful therapies like CAR-T cell treatments.
- Bioinformatics and Data Science in Cancer Research: Aimed at computational biologists, this course delves into big data analysis for pediatric oncology, using tools like R, Python, and machine learning to analyze genomic datasets from CCRI's biobanks. It includes modules on AI-driven prediction models for cancer prognosis.
- Immunotherapy and Precision Medicine: This advanced training explores targeted therapies, including monoclonal antibodies and gene editing (CRISPR). Lectures and practicals cover personalized medicine approaches, with emphasis on rare childhood cancers like neuroblastoma and sarcomas.
- Clinical Research Fellowship: For medical professionals, this year-long program integrates clinical observation at St. Anna Children's Hospital with research projects on supportive care, survivorship, and late effects of cancer treatments. It includes multidisciplinary team training involving psychologists, nurses, and pharmacologists.
CCRI's programs are designed for PhD students, postdocs, and early-career scientists, fostering international collaboration. Participants gain access to state-of-the-art facilities, including flow cytometry labs, animal models, and patient-derived xenografts. The institute emphasizes interdisciplinary approaches, integrating biology, chemistry, and data science to accelerate breakthroughs in curing childhood cancers. Annual symposia and guest lectures from global experts enhance the learning experience. With a commitment to open science, trainees are encouraged to publish findings and contribute to CCRI's ongoing clinical trials. These offerings not only build expertise but also contribute to the global fight against pediatric malignancies, ultimately aiming to increase survival rates and quality of life for affected children. The programs are highly selective, requiring strong backgrounds in life sciences, and often include stipends for international applicants. Through these initiatives, CCRI positions itself as a leader in pediatric cancer education and research innovation.